Page 151 - 73_04
P. 151

VOL. 73 (4), 947-962, 2007  MELATONIN MAKES ME FEEL AWAKE!...

 (3)  PINTOR, J.; MARTIN, L.; PELAEZ, T.; HOYLE C.H.V. AND PERAL, A. (2001) Involve-
 (4)  ment of melatonin MT3 receptors in the regulation of intraocular pressure in
 (5)  rabbits. Eur. J. Pharmacol. 416: 251-254.
 (6)  Weinreb R.N. and Khaw P.T. (2004) Primary open-angle glaucoma. The Lan-
 (7)  cet. 363:1711-1720.
 (8)  PINTOR, J. (2005) Nuevas perspectivas farmacológicas de la melatonina en el
 (9)  tratamiento de las patologías oculares. An. R. Acad. Nac. Farm. 71: 429-438.
(10)  PINTOR, J.; PELAEZ, T.; HOYLE C.H.V. AND PERAL, A. (2003) Ocular hypotensive
(11)  effect of melatonin receptor agonists in the rabbit: further evidence for an
      MT3 receptor. Brit. J. Pharmacol. 138: 831-836.
(12)  SERLE, J.B.; WANG, R.-F.; PETERSON, W.M.; PLOURDE R. AND YERXA, B.R. (2004)
(13)  Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist on intrao-
(14)  cular pressure in glaucomatous monkeys eyes. J. Glaucoma. 13: 385-388.
(15)  ALARMA-ESTRANY, P.; CROOKE, A.; PERAL, A. AND PINTOR, J. (2007) Requirement
(16)  of intact sympathetic transmission for the ocular hypotensive effects of
(17)  melatonin and 5-MCA-NAT. Auton. Neurosc.: Basic and Clinical. In press.
(18)  PINTOR, J.; CARRACEDO, G.; MEDIERO, A.; GUZMAN-ARANGUEZ, A.; IRAZU, M.; PELAEZ,
      T. AND PERAL, A. (2005) Melatonin increases the rate of re-epithelialization in
      New Zealand white rabbits. Invest. Ophthalmol. Vis. Sci. 46: A2152.
      HOYLE, C.H.V.; PERAL, A. AND PINTOR, J. (2006) Melatonin potentiates tear
      secretion induced by diadenosine tetraphosphate in the rabbit. Eur. J. Phar-
      macol. 552: 159-161.
      NOSJEAN, O.; NICOLAS, J.-P.; KLUPSCH, F.; DELAGRANGE, P.; CANET E. AND BOUTIN,
      J. A. (2001) Comparative pharmacological studies of melatonin receptors:
      mt1, mt2 and mt3/qr2. Tissue distribution of mt3/qr2. Biochem. Pharmacol.
      61: 1369-1379.
      MAILLIET, F.; FERRY, G.; VELLA, F.; THIAM, K.; DELAGRANGE P. AND BOUTIN, J.A.
      (2004) Organs from mice deleted for NRH:quinone oxidoreductase 2 are
      deprived of the melatonin binding site MT3. FEBS Lett. 578: 116-120.
      MULLINS, U.L.; FERNANDES, P.B. AND EISON, A.S. (1997) Melatonin Agonists
      Induce Phosphoinositide Hydrolysis in Xenopus laevis Melanophores. Cell.
      Signal. 9: 169-173.
      ALARMA-ESTRANY, P. AND PINTOR, J. (2007) Melatonin receptors in the eye:
      Location, second messengers and role in ocular physiology. Pharmacol. Ther.
      113: 507-522.
      DUBOCOVICH, M.L. (1995) Melatonin receptors: Are there multiple subtypes?,
      Trends Pharmacol. Sci. 16: 50-56.
      REPPERT, S.M.; WEAVER, D.R. AND EBISAWA, T. (1994) Cloning and characteri-
      zation of a mammalian melatonin receptor that mediates reproductive and
      circadian responses. Neuron. 13: 1177-1185.
      REPPERT, S.M.; WEAVER, D.R.; EBISAWA, T.; MAHLE, C.D. AND KOLAKOWSKI, L.F.
      (1996) Cloning of a melatonin-related receptor from human pituitary. FEBS
      Letts. 386: 219-224.
      NOSJEAN, O.; FERRO, M.; COGE, F.; BEAUVERGER, P.; HENLIN, J.; LEFOULON, F. AND
      DELAGRANGE, P. (2000) Identification of the melatonin-binding site MT3 as the
      quinone reductase 2. J. Biol. Chem. 275: 31311-31317.

                            961
   146   147   148   149   150   151   152   153   154   155   156